These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C. J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632 [Abstract] [Full Text] [Related]
28. Measures of obesity and metabolic syndrome in Indian Americans in northern California. Misra KB, Endemann SW, Ayer M. Ethn Dis; 2006 Oct; 16(2):331-7. PubMed ID: 17682232 [Abstract] [Full Text] [Related]
29. Prevalence of insulin resistance syndrome in a primary health care center in Kuwait. Al-Shaibani H, El-Batish M, Sorkhou I, Al-Shamali N, Al-Namash H, Habiba S, Al-Qallaf B. Fam Med; 2004 Sep; 36(8):540. PubMed ID: 15343411 [No Abstract] [Full Text] [Related]
31. The metabolic syndrome and its cardiovascular manifestations. Sánchez-Torres RJ, Delgado-Osorio H. Bol Asoc Med P R; 2005 Sep; 97(4):271-80. PubMed ID: 16599068 [Abstract] [Full Text] [Related]
33. Obesity increases metabolic syndrome risk factors in school-aged children from an urban school in Mexico city. Perichart-Perera O, Balas-Nakash M, Schiffman-Selechnik E, Barbato-Dosal A, Vadillo-Ortega F. J Am Diet Assoc; 2007 Jan; 107(1):81-91. PubMed ID: 17197275 [Abstract] [Full Text] [Related]
34. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events. Mancia G, Bombelli M, Facchetti R, Casati A, Ronchi I, Quarti-Trevano F, Arenare F, Grassi G, Sega R. J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922 [Abstract] [Full Text] [Related]
35. Metabolic syndrome and its characteristics among obese patients attending an obesity clinic. Termizy HM, Mafauzy M. Singapore Med J; 2009 Apr; 50(4):390-4. PubMed ID: 19421683 [Abstract] [Full Text] [Related]
37. Glucose metabolism in patients with essential hypertension. García-Puig J, Ruilope LM, Luque M, Fernández J, Ortega R, Dal-Ré R, AVANT Study Group Investigators. Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774 [Abstract] [Full Text] [Related]
38. Clustering of coronary artery disease risk factors in patients with type 2 diabetes and impaired glucose tolerance. Sajjadi F, Mohammadifard N, Kelishadi R, Ghaderian N, Alikhasi H, Maghrun M. East Mediterr Health J; 2008 Apr; 14(5):1080-9. PubMed ID: 19161080 [Abstract] [Full Text] [Related]
39. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients. Vlek AL, van der Graaf Y, Spiering W, Visseren FL, SMART study group. J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039 [Abstract] [Full Text] [Related]
40. Metabolic syndrome. Mardarowicz G, Lopatyński J, Nicer T. Ann Univ Mariae Curie Sklodowska Med; 2003 May; 58(1):426-31. PubMed ID: 15315027 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]